AtriCure, Inc. (NASDAQ: ATRC) reported Q1 EPS of ($0.31), $0.09 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $24.8 million versus the consensus estimate of $23.36 million.

AtriCure, Inc. sees FY2014 revenue of $101-104 million, versus prior guidance of $100-103 million and the consensus of $101.91 million.

For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.